NC
TNDM icon

Nicholas Company’s Tandem Diabetes Care TNDM Stock Holding History

Nicholas Company’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-47,380
Closed -$2.8M – 230
2022
Q2 		$2.8M Sell
47,380
-109,493
-70% -$8.99M 0.06% 216
2022
Q1 		$18.2M Buy
156,873
+175
+0.1% +$20.4K 0.33% 82
2021
Q4 		$23.6M Sell
156,698
-14,065
-8% -$1.9M 0.38% 72
2021
Q3 		$20.4M Buy
170,763
+16,735
+11% +$1.84M 0.36% 76
2021
Q2 		$15M Buy
154,028
+59,840
+64% +$5.34M 0.26% 110
2021
Q1 		$8.31M Buy
94,188
+3,045
+3% +$283K 0.16% 161
2020
Q4 		$8.72M Buy
91,143
+34,883
+62% +$3.6M 0.17% 147
2020
Q3 		$6.39M Buy
+56,260
New +$5.91M 0.13% 165

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nicholas Company's TNDM Position: Q3 2022 in Review

Nicholas Company sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 47,380 shares — an estimated $2.8M sold.

Nicholas Company first reported a position in TNDM in Q3 2020 and held it in 8 quarters. The position peaked at $23.6M in Q4 2021. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

  • Nicholas Company reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
  • Nicholas Company sold 47,380 Tandem Diabetes Care shares in Q3 2022, an estimated $2.8M.
  • Nicholas Company first reported a position in Tandem Diabetes Care in Q3 2020 and held it in 8 quarters.
  • Nicholas Company's Tandem Diabetes Care position peaked at $23.6M in Q4 2021.
  • 299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on Nicholas Company's 13F filing for Q3 2022, filed 14 Nov 2022.